Article Text

Download PDFPDF
Delivery of bronchodilators in acute asthma in children
  1. Craig Ferguson, Clinical Research Fellow,
  2. Shweta Gidwani, Clinical Effectiveness Fellow
  1. Manchester Royal Infirmary

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    A short cut review was carried out to establish whether delivery of bronchodilators to children was better by spacer device or nebuliser. 1456 papers were found using the reported searches, of which four presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. It is concluded that in most cases where a child presents with moderate to severe asthma beta-2-agonists could be delivered via a spacer device in place of a nebuliser.

    Clinical scenario

    A seven year old child with a known history of asthma presents with a 24 hour history of exacerbation of wheeze. He has been using his salbutamol inhaler with little benefit. You prescribe a ß-agonist by nebuliser but wonder if it …

    View Full Text


    • Report by Craig Ferguson, Clinical Research FellowChecked by Shweta Gidwani, Clinical Effectiveness FellowManchester Royal Infirmary